Medicine and Dentistry
Adenocarcinoma
8%
Adjuvant Chemotherapy
5%
Adjuvant Therapy
6%
Allograft
6%
Bariatric Surgery
20%
Bile Duct
8%
Biopsy
7%
Bleeding
10%
Body Mass Index
11%
Cancer
11%
Carcinoid
5%
Chemoradiotherapy
11%
Cholangiocarcinoma
85%
Cholangiocyte
5%
Colorectal Cancer
5%
Diabetes Mellitus
7%
Diagnosis
7%
Disease
32%
Disease Free Survival
6%
Distal Pancreatectomy
10%
Endoscopic Ultrasound
5%
Ex Vivo
5%
Gastric Bypass
5%
Gastric Bypass Surgery
5%
Graft Survival
10%
Gut
5%
Gut Microbiome
8%
Hazard Ratio
11%
Hepatectomy
46%
Hepatic Portal Vein
5%
Hepatitis C
8%
Hepatocellular Carcinoma
15%
Hepatocyte
11%
Infection
7%
Interstitial Cell of Cajal
5%
Intraductal Papillary Mucinous Tumor
10%
Liver Cirrhosis
6%
Liver Disease
12%
Liver Failure
5%
Liver Graft
18%
Liver Metastasis
13%
Liver Transplantation
92%
Long Term Survival
5%
Lymph Node
8%
Magnetic Resonance Imaging
9%
Malignant Neoplasm
37%
Metastatic Carcinoma
22%
Microbiome
8%
Neoadjuvant Chemotherapy
8%
Neoadjuvant Therapy
15%
Neoplasm
59%
Neuroendocrine Tumor
11%
Nonalcoholic Fatty Liver
8%
Odds Ratio
7%
Overall Survival
29%
Pancreas Adenocarcinoma
22%
Pancreas Cancer
26%
Pancreas Islet Cell Tumor
5%
Pancreatectomy
9%
Pancreatic Surgery
5%
Pancreaticoduodenectomy
35%
Patient Referral
6%
Postoperative Complication
7%
Prevalence
5%
Primary Sclerosing Cholangitis
16%
Programmed Cell Death
9%
Proportional Hazards Model
5%
Quality of Life
7%
Recurrent Disease
24%
Roux-en-Y Gastric Bypass
9%
Stomach Paresis
6%
Surgeon
10%
Surgery
100%
Survival Rate
9%
Symptom
12%
The Cancer Genome Atlas
5%
Transplantation
11%
Tyrosinemia
5%
Xenograft
6%
Keyphrases
5-year Survival
7%
Bariatric Surgery
7%
Carbohydrate Antigen 19-9 (CA19-9)
6%
Chemotherapy
5%
Cholangiocarcinoma
27%
Cholangiocarcinoma Cells
5%
Clinical Outcomes
7%
Confidence Interval
7%
Consecutive Patients
5%
Curative Resection
5%
Graft Survival
6%
Hazard Ratio
7%
Hepatectomy
5%
Hepatic Resection
10%
Hepatitis C
6%
Hepatocellular Carcinoma
12%
Hilar Cholangiocarcinoma
12%
Interstitial Cells of Cajal
6%
Intraductal Papillary mucinous Neoplasm
5%
Liver
13%
Liver Resection
8%
Liver Transplant Recipients
8%
Liver Transplantation
71%
Living Donor Liver Transplantation
6%
Malignancy
5%
Mayo Clinic
11%
MELD Score
7%
Metastasis
5%
Microbiome
8%
Neoadjuvant Chemoradiotherapy (nCRT)
7%
Neoadjuvant Chemotherapy
5%
Neoadjuvant Therapy
9%
Nonalcoholic Steatohepatitis
7%
Operative
7%
Orthotopic Liver Transplantation
14%
Overall Survival
16%
Pancreas
5%
Pancreatic Adenocarcinoma
5%
Pancreatic Cancer
12%
Pancreatic Ductal Adenocarcinoma
8%
Pancreaticoduodenectomy
13%
Patient Selection
8%
Patient Survival
7%
Perihilar Cholangiocarcinoma
12%
Postoperative Mortality
5%
Pretransplant
7%
Primary Sclerosing Cholangitis
14%
Recurrence Rate
5%
Resection
23%
Risk Factors
9%
Surgical Resection
8%
Surgical Treatment
5%
Transplantation
19%
Treatment Options
5%
Tumor
12%
Tumor Size
5%